We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

GMP Certification Boost for Cobra Biologics

Extended certification to include QC testing of registered products.
News

Ario Pharma Commences Phase IIa Trial of TRPV1 Inhibitor for Cough

Short duration study, expected to complete Q3, 2014.
News

Debiopharm to Acquire Affinium’s Antibiotic Clinical Assets and Platform

Company acquire clinical and preclinical assets to identify and develop targeted antibiotics.
News

NIH, Industry and Non-Profits Join Forces to Speed Validation of Disease Targets

Goal is to develop new treatments earlier, beginning with Alzheimer's, type 2 diabetes, and autoimmune disorders.
News

Nanobiotix Sees Clinical Advance in STS Pilot Trial with Lead Product, NBTXR3

Market development plan outlined for earlier potential launch in 2016.
News

A Crisper View of DNA-Snipping Enzyme

HHMI scientists have created a portrait of a DNA-snipping protein called Cas9, a powerful research tool used in many labs for genome editing.
News

Sosei Signs Distribution Agreement with FUJIFILM Pharma

Distribution agreement for commercialization of SO-1105 in Japan.
News

Merck Enters Strategic Collaborations with Amgen, Incyte and Pfizer

Merck also to initiate Phase I “signal finding” study with MK-3475 in 20 new cancer types.
News

Phillips-Medisize Signs Supply Agreement with Sanofi

Company wins new supply contract for Sanofi injection pen components.
News

Translational Imaging Center to Speed Drug Development, Lower Costs

First-of-its-kind facility to begin operations in early spring.
Advertisement